7 medtech stories we missed this week: Oct. 20, 2017

[Image from unsplash.com]From InspireMD’s distribution deal to RenalGuard touting a new study, here are seven medtech stories we missed this week but thought were still worth a mention.
1. InspireMD inks Chile distribution deal
InspireMD announced in an Oct. 12 press release that it has signed a distribution deal with CorpMedical Chile to distribute the MGuard Prime Embolic Protection System (EPS). The MGuard Prime EPS treats acute coronary syndromes like acute myocardial infarctions.
2. Medacta launches MiniMed hip stem
Medacta has launched its MiniMAX Hip System in the U.S., according to an Oct. 12 press release. MiniMAX is an anatomical cementless stem that is engineered to provide enhanced fit and fill in the metaphyseal femur. It follows the natural shape of the femoral canal for minimally-invasive anterior and posterior hip replacement procedures.
3. Esaote launches MyLab 9 ultrasound
Esaote announced in an Oct. 13 press release that it has launched its MyLab 9 ultrasound platform. MyLab 9 has smart upgradability, remote serviceability, long-term maintenance options and transducer compatibility.
4. Subchondral system wins FDA nod for orthopedic screw system
Subchondral Solutions has received FDA 510(k) clearance for its S4 Screw System, according to a Sept. 29 press release. The S4 Screw System is a fenestrated cannulated screw set that is designed for osteochondral fractures of the joint. The clearance allows for the company to begin commercializing its produc...

Source: Mass Device - October 20, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Cardiovascular Clinical Trials Diagnostics Food & Drug Administration (FDA) Implants Orthopedics Patient Monitoring Regulatory/Compliance Surgical Ultrasound Esaote Hill-Rom Holdings Inc. Honeywell InspireMD Medacta Source Type: news